Overview

Project 2 Airway Potential Hydrogen (pH) in Asthma

Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This study is testing a non invasive way to measure airway pH in individuals with Asthma and Cystic Fibrosis using a new inhaled drug. The airway pH will help health care providers in creating tailored treatment plans for individuals suffering from these specific conditions.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborator:
National Institutes of Health (NIH)
Treatments:
Glycine